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Eosinophils were shown to playa major role in the allergic 
inflammatory process leading to the clinical symptoms of 
atopic dermatitis. Only selected cytokines are capable of in-
ducing a chemotactic response in eosinophils. In particular, 
the chemokine RANTES was recently shown to be a potent 
eosinophil chemotaxin. To examine the role ofRANTES in 
eosinophil activation, we investigated the effect ofRANTES 
and other chemokines on morphology and oxidative metab-
olism of highly purified eosinophils of normal nonatopic 
blood donors by assessment of functional as well as morpho-
logic criteria. RANTES, and, to a lesser extent, MIP-la sig-
nificantly induced the production of reactive oxygen species 
by human eosinophils, whereas MCP-l, MIP-lj3, and inter-
leukin (IL)-8/NAP-l had no significant effects. RANTES 
stimulated only a subpopulation of the normal eosinophils. 
With the exception ofIL-8, none of the cytokines tested had 
any significant effect on polymorphonuclear neutrophilic 
granulocytes: By scanning electron microscopy, RANTES 
E osinophils are thought to be of major importance as ef-fector cells mediating the pathogenetically relevant late-phase reaction, which is associated with significant de-struction of the surrounding tissue [1] . Recent evidence indicates that these cells play an important role in the 
propagation of the inflammatory response in atopic diseases, partic-
ularly in bronchial asthma [2,3] and atopic dermatitis [4,5]. Immi-
gration and local activation of eosinophils represent characteristic 
signs of atopic inflammation. The mechanisms of tissue-specific 
eosinophil recruitment and activation are not fully understood at 
present and involve a complex interplay of various pathways [6]. 
Several humoral mediators and cytokines are capable of activating 
the functional activity of eosinophils, e.g., C5a, platelet-activating 
factor, interleukin (IL)-5, and IL-3, granulocyte-macrophage col-
ony stimulating factor (GM-CSF) . Whereas IL-5 was shown to be 
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induced characteristic changes that were completely abro-
gated in the presence of cytochalasin B. Based on functional 
and ultrastructural assays significant extracellular but not in-
tracellular H 20 2 production was detected and completely 
inhibited by cytochalasin B. Separation of eosinophils by 
discontinous density gradients revealed the existence of 
two hypodense eosinophil populations, one which showed 
significantly reduced responses upon stimulation with 
RANTES. RANTES-induced production of reactive oxygen 
species was almost completely inhibited by staurosporine, 
wortmannin, or pertussis toxin. Based on these data it is 
evident that RANTES represents a potent eosinophil-specific 
activator of oxidative metabolism. Besides its chemotactic 
activity on T cells and eosinophils, therefore, RANTES may 
be involved in the functional activation of eosinophils in the 
skin of patients with atopic dermatitis. Key words: ultrastruc-
ture/cytokines/chemiluminescence/hydrogen peroxide. J Invest 
DermatoI102:906-914,1994 
an eosinophil-selective chemoattractant [7] and trigger of the oxi-
dative burst [8,9], the effect of other stimuli is not specific for eosin-
ophils but may also trigger the metabolic activity of other leuko-
cytes, particularly of polymorphonuclear neutrophilic granulocytes 
(PMNs). Very recently, a novel family oflow molecular mass cyto-
kines with distinct structural and functional homology has been 
defined, the RANTES/SIS cytokine family, which is identical with 
the C-C branch of the Platelet Factor 4/intercrine superfamily, 
recently renamed the "chemokine superfamily" [10]. RANTES, a 
member of that family originally described as a "memory" T -cell-
selective attractant was shown to be a potent chemotaxin for human 
eosinophils, but not for human PMNs [11-13]. Chemotactic mi-
gration of cells, however, is often associated with the activation of 
the oxidative burst. To examine the potential role of RANTES in 
eosinophil activation, we investigated the effect of RANTES on 
morphology and oxidative metabolism of highly purified eosino-
phils of normal nonatopic blood donors in comparison with IL-S 
and GM-CSF. 
MATERIALS AND METHODS 
Cytokines and Stimuli Recombinant human RANTES, MIP-1cx, and 
MIP-1P were a kind gift from Dr. T. Schall, Genentech, San Francisco, CA. 
Recombinant human MCP-1 (MCAF) was obtained from Pepro Tech, 
Rocky Hill, NJ. Recombinant human leukemia inhibiting factor (LIF), 
IL-5, GM-CSF, and monocyte-derived IL-8 were from Genzyme, Cam-
bridge, MA. Before testing, all cytokines were diluted in phosphate-buffered 
saline (PBS) containing 50 J1g/ml bovine serum albumin (BSA). Escherichia 
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coli - derived recombinant human C5a was obtained from Sigma, Munich, 
Germany. 
Reagents and Antibodies Ficoll-Paque solution was obtained from 
Pharm.acia (Freiburg, Germany); purified BSA, lucigenin, luminol, phor-
bol-m.yristate-acetate (PMA), horse radish peroxidase type I, catalase, and 
cytochalasin B were obtained from Sigma. Staurosporine and pertussis-toxin 
were from Calbiochem-Novabiochem, Bad Soden, Germany. Wortmann in 
was a kind gift from Dr. D. Romer, Sandoz, Basel, Switzerland. Culture 
media and antibiotics were purchased from Biochrom-Seromed (Berlin, 
Germ.any). CeC1J was from Flub, Buchs, Switzerland. Reagents and media 
for electron microscopy were obtained from Roth, Karlsruhe, Germany. A 
monoclonal mouse immunoglobulin (Ig) G2a against CD16 (BW 209/2) 
was a gift from Dr. R. Kurrle, Behring Werke, Marburg, Germany. 
Isolation of Human Granulocytes Human granulocytes were isolated 
frorn heparin-anticoagulated venous blood of normal nonatopic blood 
donors as described previously [14]. For further purification of eosinophils, 
granulocytes were resuspended at a concentration of 107 /ml in HEPES-buf-
fered Hanks' balanced salt solution, pH 7.4, containing 1 mg/ml BSA 
(HBSSjBSA). 
purification of Human Eosinophilic Granulocytes Eosinophils were 
purified in a modification of a method described previously [15J. For this 
purpose immunomagnetic beads (Dynabeads M-450, Dynal, Norway) were 
coated with monoclonal aCD16. In brief, 2 ml beads (4 X 108 beads/ml) 
were m.ixed with 50 III aCD16 (1 mg/ml) and incubated for 24 hat 4 'C in 
Minisorp tubes (Nunc, Roskilde, Denmark) on a rotary mixer. Coated beads 
were washed three times in HBSS/BSA and the beads retrieved using a 
Dynal Magnetic Particle Concentrator MPC-6. aCD16-coated beads were 
stored at a concentration of 2 X 108 beads/ml HBSS/BSA under sterile 
conditions for a maximum of 1 week at 4' C. One milliliter of granulocytes 
was centrifuged in Minisorp tubes for 7 min at 820 X g at 4' C, the superna-
tant was aspirated, and subsequently 500 III of the aCD 16-coated beads was 
added to the pellet. The mixture was incubated for 1 h at 4 ' C on a rotary 
mixer. Thereafter, HBSS/BSA was added and PMNs, which were coupled 
ro the beads, were removed magnetically using the MPC-6 device. The 
supernatant was aspirated and residual beads were removed by a second 
magnetic separation step. The resulting supernatant was washed as described 
above and the resulting eosinophils were resuspended in HBSS/BSA. If 
necessary, the magnetic purification procedure was repeated once more. 
Eosinophils were quantitated with Kimura stain [16] in a Neubauer counting 
chamber. Cytospin preparations of the cells had a purity of> 95% as shown 
by Pappenheim stain. 
Separation of Eosinophils on Diseontinous Percoll Gradients 
Highl y purified eosinophils were further separated by centrifugation on 
Percoll (Kabi Pharmacia, Freiburg, Germany) density gradients [17]. For this 
purpose five-step discontinous density gradients (750 III of each interface per 
gradient) were formed with a peristaltic pump (Varioperpex II pump; Kabi-
Pharm.acia) in 5-ml round-bottom polystyrene-tubes. In brief, gradients 
consisted of 1.08, 1.085, 1.09, and 1.1 g/ml isotonic buffered Percoll solu-
tion [17]. Eosinophils (5 X 106), purified as described above, were washed 
twice and resuspended in 750 III Percoll solution (density of 1.07 g/ml). 
Percoll gradients were overlaid with these cells and centrifuged for 20 min at 
1600 X gat 10'C. Thereafter, the cells in the interphases were collected, 
immediately washed twice with HBSS/BSA, and resuspended as described 
below. Eosinol?hils with a density of < 1.082 g/ml were defined as being 
hypo dense [18J. Cells were stained and counted as described above; there 
were no differences in viability of the cells (92-95%) between the fractIOns, 
35 judged by trypan blue exclusion. 
Lucigenin-Dependent Chemiluminescence (CL) Lucigenin-depen-
dent CL [9,19], which, in contrast to the luminol-enhanced reaction, is 
independent from the release of peroxidase [20], represents an extremely 
sensitive measure of the release of reactive oxygen species (ROS) from 
granulocytes. However, the CL response is not known to be strongly corre-
lated with the production of a particular ROS. For simultaneous measure-
ment of large samples (dose-response relations), a single-photon imaging 
system. with a two-dimensional photon counting system (MTP reader; Ha-
mamatsu Photonics, Herrsching, Germany) was used as described elsewhere 
[21,22]. In brief, eosinophils were suspended to a density of5 X 10' cells/ml 
in HE PES-buffered HBSS, pH 7.4, containing 200 11M lucigenin and t mg/ 
ml BSA. Aliquots (100 Ill) containing 5 X 10J cells each were placed into 
flat-bottom white microtiter plates (Microfluor; Dynatech Deutschland, 
Denkendorf, Germany). Measurements were performed in triplicate at 
37°C. Integral counts from a 0 - 60-min incubation interval after rhe addi-
tion of stimuli to the eosinophils were measured; they are indicated as 
integral intensity counts X lO- J in Figs t- 7 and Table I. 
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For CL time-kinetic studies, eosinophils were suspended to a density of 
2.5 X lOs cells/ml in HEPES-buffered HBSS, pH 7.4, containing 200 JIM 
lucigenin and 1 mg/ml BSA. Aliquots (200.uI) containing 5 X 10' cells 
each were placed into unsealed polystyrene luminescence tubes (Berthold, 
Wildbad, Germany) and stored at 4 'C for a maximum of 2 h prior to use. 
Measurements were performed at 37'C in two six-channel Biolumat LB 
9505C (Berthold). Integral counts from a 0-60-min incubation interval 
after addition of stimuli co the granulocytes were measured, indicated as 
counts X 10- 6 in Fig 3. 
Extracellular and Intracellular Production of H.O. Extracellular 
and intracellular production ofH.02 were determined using a modification 
of a sensitive chemiluminescence technique described previously [23,24]. In 
brief, 50 III eosinophils at a concentration of2 X 105/ ml HBSS/ BSA were 
distributed into flat-bottom white microtiter plates. Subsequently, 50 III of 
the reaction mixtures were added and incubated with cells for 20 - 30 min at 
37 ' C. Subsequently, stimuli or medium as control were added. Measure-
ments were performed in triplicate at 37'C. Integral counts from a 0-60-
min incubation interval after addition of stimuli to the eosinophils were 
measured and indicated as integral intensity counts X lO- J. The reaction 
mixtures for measurement of extracellular H20 2 production consisted of 
2 mM NaNJ, 9 U/ ml horseradish peroxidase (HRPO) type I, and 10-6 M 
luminol with or without the addition of 10 .ug/ ml cytochalasin B, whereas 
the cocktail used for detection of intracellular H 20 2 production contained 
4 X 10J U/ml catalase and 10-6 M luminol with or without the addition of 
lOllg/ml cytochalasin B. 
Release of Eosinophil Peroxidase (EPO) and Eosinophil Cationic 
Protein (ECP) For measurement of EPO and ECP release, eosinophils 
were suspended at a concentration of 5 X 105/ml HBSS/BSA in 96-well 
V-bottom tissue culture plates using 5 X 10' cells/well. After preincubation 
of the eosinophils for 5 min at 37 'C in the presence or absence of 5 Ilg/ ml 
cycochalasin B, stimuli or medium were added. Thereafter eosinophi ls were 
mcubated for 30 or 120 min at 37 'C, slightly shaken on a Titertek micro-
plate shaker. Following this incubation, cells were sedimented by centrifu-
gation for 5 min at 600 X g at 4 'C and supernatants were removed carefully. 
Subsequently, 100 It! 0.3% cetyl-trimethylammonium bromide (CETAB) 
was added to 100111 supernatant each and the mixtures were immediately 
frozen at -70'C until testing. For EPO measurement a highly sensitive 
e.nhanced luminescence assay was used. In brief, 100 III ECL immunoassay 
Signal reagent free of NaNJ (Amersham, Braunschweig, Germany) was 
added to 10 III supernatant in flat-bottom white microtiter plates. Measure-
ments were performed in triplicate for 30 min at 37 ' C. EPO activity con-
~amed m the supernatants was expressed as intensity integral counts X 10- J 
m Fig 7. Interassay reproducibility was tested by means of standard curves 
using serial dilutions of eosinophil lysates (50% to 0.5% of total content). 
Eosinophil Iysates were generated as follows: 200 III 0.6% CETAB was 
added to 100 III eosinophils at a concentration of 5 X 105/ ml, the mixture 
w~s mcubated for 60 min at room temperature on a shaker, centrifuged for 5 
mm at 600 X g at 4 'C, and the supernatant was immediately frozen at 
-70'C. EC::P concemration in the supernatants was determined by means of 
a commercially available double antibody radioimmunoassay (ECP-RIA; 
Kabi-Pharmacia) [25]. 
Ultrastructural Det~ction of Eosinophil Activation To evaluate the 
effect.of stlmult on eosmophils by ultrastructural criteria [26,27]' eosinophils 
~ere mcubated ~ta concemration oft X 106/ ml in microtubes fortransmis-
Slon and sca~run~ electron microscopy, respectively (TEM and SEM). 
Thereaft~~, stimuli or medium were added to the eosinophils. I.mmediately, 
after addlt10n of the stimuli, 30 III of the mixture was transferred to Bio Rad 
adhesion slides (Bio Rad, Munich, Germany) and incubated for 30 min at 
37'C. Thereafter, eosinophils were fixed for TEM or SEM as described 
below [26,27]. In brief, eosinophils were fixed in 2.5% glutaraldehyde in 
0.1 M sodium cacodylate buffer, pH 7.3, for 60 min at 4 'C. 
For detection of hydrogen peroxide production, eosinophils were incu-
bated at a density of 1 X 106/ml with stimuli or medium in microtubes for 
30 min at 37 ' C as described [9]. Briefly, after centrifugation unfixed cells 
were pre incubated for 10 min at 37'C in 0.1 M Tris-Maleate with 7% 
sucrose, pH 7.5. The final incubation medium consisted of 0.1 M Tris-
Maleate with 7% sucrose, pH 7.5, and 1 mM CeCIJ. Eosinophils were 
mcubated for 30 min at 37 ' C in this medium, fixed as described above, and 
subsequently washed in sodium cacodylate buffer, pH 6.0, with 5% sucrose 
for 60 min at 4 ' C . 
Generally, eosinophils were washed overnight in 0.1 M sodium cacody-
late buffer, pH 7.3, with 5% sucrose, postfixed in 1 % osmium tetroxide in 
the same buffer for 60 min, dehydrated in graded ethanols, and embedded in 
Araldit. Thin sections were routinely stained with 4% aqueous uranyl ace-
tate and lead citrate and examined in a Zeiss EM 1 09. 
For SEM, eosinophils were fixed in glutaraldehyde and postfixed in os-
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Table I. Effect of Chemotactic Cytokines on Eosinophil Oxidative Metabolism 
Cytokine Concentration' (ng/ml) Integral Counts X 10- 3 b N p versus MED 
RANTES 
MCP-l 
MIP-la 
MIP-l/1 
HILDA/LIF 
NAP- l/IL-8 
MED' 
• Maximal concentration of cytokine tested. 
b Mean ± SEM. 
100 
100 
100 
100 
100 
100 
, Background induced by addition of medium alone. 
mium tetroxide as described above. Samples were dehydrated in a graded 
series of ethanol (30-100%), critical-point dried, gold-coated, and exam-
ined in a Jeol JSM-35CF scanning microscope. 
Statistical Analysis Unless otherwise stated, the data in the text and 
figures were expressed as mean ± SEM. All data were analyzed nonparame-
trically using the Mann-Whitney U-test. Significance was accepted for 
p:5 0.05. 
RESULTS 
Effect of RANTES on the Morphology of Human Eosino-
phils By SEM, unstimulated eosinophils were rounded, with a 
ruffled surface membrane (Fig lA). Upon stimulation with 
RANTES (100 ng/ml) only a subpopulation of the eosinophils ap-
peared to be firmly adherent to the glass surface, exhibiting a char-
acteristic spindle-like shape, whereas the remaining cells retained 
their spherical shape (Fig IB). Because eosinophil preparations of 
97 - 99% purity were used in these experiments, unstimulated cells 
did not represent contaminating PMNs. In contrast to stimulation 
with RANTES, all eosinophils treated with IL-5 (102 U/ml) ad-
hered to the glass surface cells, developing long pseudopodia-like 
protrusions, mainly at one side of the cell (Fig le). Morphologic 
changes induced by GM-CSF (102 U Iml) were quite different; eo-
sinophils were flattened and developed a large broad pseudopodium 
(Fig ID). Stimulation of eosinophils in the presence of cytochalasin 
B, which interferes with the contractile microfilament functions 
[28], comrletely abrogated the characteristic morphologic transfor-
mation 0 the cells by all cytokines tested (data not shown). 
By TEM, unstimulated eosinophils contained dense, specific 
granules displaying centrally located cristalloid cores and an outer 
matrix, all bounded by a typical granule membrane (Fig lE). Only a 
few small dense, membrane-bound granules and some vesiculotu-
bular structures were seen. Golgi vesicles, mitochondria, and other 
organelles appeared to be normal. After addition ofRANTES to the 
eosinophils, only a part of the cells showed characteristic signs of 
activation; some secondary granules of the eosinophils lost portions 
or all of the normally dense matrix (see arrow in Fig IF). In some 
cells unchanged dense cores remained in an otherwise empty mem-
brane-bound granule. In addition, RANTES induced the appear-
ance of vesicular structures in the matrix of specific granules (Fig 
IF) and increased numbers of small electron-dense cytoplasmic 
granules. Many electron-lucent vesicles derived from the strongly 
activated Golgi apparatus were found. IL-5, however, mediated the 
generation of increased numbers of specific granules containing 
vesicular structures in the matrix, as compared to stimulation with 
RANTES (note arrow in Fig IG) . Like RANTES, IL-5 produced 
numerous small electron-dense granules as well as electron-light 
vesicles. Increased numbers of cytoplasmic lipid bodies, distinct 
from unstimulated cells, were observed upon stimulation with IL-5 
(Fig IG). Upon stimulation with GM-CSF, vesicular structures 
were present in the matrix of only a few specific granules (note arrow 
in Fig IH). In contrast to stimulation with RANTES, GM-CSF 
produced fewer small electron-dense granules. Like IL-5, upon 
stimulation with GM-CSF increased numbers of cytoplasmic lipid 
bodies were observed (Fig IH) . In general, no characteristic 
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4 
9 
0.001 
NS 
0.01 
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signs of piecemeal degranulation, however, were detected with any 
of the stimuli tested. 
Effects ofRANTES on the Chemiluminescence Response of 
Human Eosinophils RANTES induced a dose-dependent pro-
duction of reactive oxygen species (ROS) as me"sured by lucigenin-
dependent chemiluminescence. Significant effects were observed 
even in the range ofl0-100 ng/ml (Fig 2A); higher concentrations 
were inhibitory (data not shown). Maximal responses upon stimula-
tion with GM-CSF or IL-5, however, were significantly higher 
than optimal effects induced by RANTES (Fig 2B). Moreover, the 
dose-response relation of RANTES-induced effects was focused on 
a small range of concentration, which was apparently different from 
effects induced by GM-CSF or IL-5 (Fig 2A,B). 
The CL response induced a typical time course starting immedi-
ately after addition of the stimulus, with a peak at about 4-6 min, 
followed by an increase of baseline activation of the eosinophils for 
about 1 h (Fig 3). In contrast, CL response upon stimulation with 
IL-5 and GM-CSF started after a lag phase oD - 5 min, with a peak 
in the range of 10-15 min, which was similarly followed by a 
long-lasting increase of baseline activity. 
In addition to RANTES, other members of the C-C branch of 
chemokines were tested. Only MIP-la was shown to induce a small 
but significant chemiluminescence response in human eosinophils 
in the range of 10-100 ng/ml (Fig 2A, Table I). The structurally 
related MIP-lfJ as well as MCP-l were inactive. Similar results were 
obtained for IL-8 and LIF/HILDA [29,30]. 
Effects ofRANTES on the Chemiluminescence Response of 
Human PMN In contrast to IL-8 or GM-CSF, which were able 
to induce a significant CL response in human PMNs, MIP-la, 
MIP-1P, and MCP-l had no measurable effect on PMNs (data not 
shown). RANTES and IL-5, however, induced small but statisti-
cally significant CL responses in PMN preparations that were con-
taminated with 4-6% eosinophils (data not shown). Therefore, 
these contaminating eosinophils could be responsible for the effects 
observed. Alternatively, CL responses might be due to the interac-
tion ofPMNs with activated eosinophils, because PMNs in mixed 
granulocyte preparations, particularly in atopic patients, are acti-
vated indirectly by factors released from IL-5 -activated eosinol.'hils 
or by an IL-5-mediated, adherence-dependent mechanism [9J . 
Effect of Inhibitors on the Chemiluminescence Response of 
Human Eosinophils Preincubation of eosinophils with 5 jlgl 
ml cytochalasin B for 5 min before addition ofRANTES (100 ngj 
mil, IL-5 (102 U/m!), or GM-CSF (102 U/m!) completely inhib-
ited the chemiluminescence response (data not shown). In contrast, 
there was only a partial inhibition when PMA (10 ng/ml) was used 
as stimulus (3264 ± 715 versus 985 ± 85 counts X 10-3; mean ± 
SEM of six blood donors) . Pretreatment of eosinophils with 
100 ng/ml pertussis toxin for 120 min at 37 °C [31] resulted in an 
almost complete inhibition (85 ± 11 %) of chemiluminescence re-
sponses induced by RANTES (Fig 4A), whereas production of reac-
tive oxygen species induced by IL-5 or GM-CSF was strongly sup-
pressed only at higher concentrations of pertussis toxin (Fig 4B). In 
VOL. 102. NO.6 JUNE 1994 
Figure 1. Effect of RANTES. IL-5. and GM-CSF on the morphology of 
human eosinophils. Ultrastructural detection of eosinophil activation in-
duced by recombinant human RANTES. IL-5. and GM-CSF. A) For unsti-
mulated eosinophils. medium was added instead of stimuli. 30 min at 37 · C. 
SEM; B) eosinophils stimulated with RANTES (100 ng/ml). 30 min at 
37°C, SEM; C) eosinophils stimulated with IL-5 (102 U/ ml), 30 min at 
37"C, SEM; D) eosinophils stimulated with GM-CSF (102 U/ml) , 30 min 
at 37 · C, SEM; E) for unstimulated eosinophils, medium was added instead 
of stimuli, 30 min at 37 ·C, TEM; F) eosinophils stimulated with RANTES 
(100 ng/ml), 30 min at 37·C, TEM; G) eosinophils stimulated with IL-5 
(102 U/ml), 30 min at 37"C , TEM; H) eosinophils stimulated with GM-
CSF (102 U/ml), 30 min at 37"C, TEM. Eosinophils used in these experi-
ments had a purity of 98-99%. The experiment is representative of six 
essentially identical experiments on eosinophi ls of healthy nonatopic blood 
donors. L, cytoplasmic lipid bodies. 
contrast, PMA-induced CL was only partially inhibited even at a 
concentration of pertussis toxin of l,ug/ml. Pretreatment of the 
eosinophils with staurosporine [32] inhibited the chemilumines-
cence responses upon stimulation with RANTES, IL-5 , or GM-CSF 
in dose-dependent fashion. Complete inhibition was observed at a 
concentration of 100 nM (Fig 4C). Pretreatment of the eosinophils 
with 1 ,uM wortmannin [33,34] totally abrogated the responses in-
duced by RANTES, IL-5, or GM-CSF (data not shown) . 
Effect of RANTES on the Chemiluminescence of Hypo-
dense and Normodense Eosinophils Separation of eosinophils 
on discontinous Percoll gradients revealed at least two hypodense 
350 
en 
I 
0 300 
-H 
., 250 .... § 
0 200 u 
I>-
:::! 
., 150 Q 
., 
.... 
. S 100 
01 
.... 
bO 50 ., 
.... 
. S 
0 
A 
1250 
l') 
I 
0 
.... 
H 1000 
., 
.... § 
0 750 u 
I>-
:::! 
III Q 500 ., 
.... 
. S 
'il 250 .... 
bO 
., 
.... 
. S 
0 
B 
RANTES-INDUCED EOSINOPHIL ACTIVATION 909 
* 
** r 
o 
0-0 RANTES 
.-. MIP-la 
r 
o ~----.~ 
** ;~e------~ 
100 10 0.1 MED 
Stimulus [ng/ml] 
0-0 GM-CSF 
.-. IL-5 
3 2 o -1 MED 
Stimulus [log U/ml] 
Figure 2. Effects ofRANTES, IL-5, and GM-CSF on the oxidative metab-
olism of human eosinophils. Chemiluminescence responses of purified eo-
smoplllls from healthy nonatopic blood donors are shown. Effect of recom-
binant human (A) RANTES, MIP-la, (B) GM-CSF, and IL-5. Integra.! 
counts (60-min) were measured using a Hamamatsu MTP reader. Values 
represent mean ± SEM of experiments on five to nine healthy nonatopic 
blood donors. MED, background, induced by addition of medium alone. 
'p::S 0.05, " p ::s 0.01, "'p ::S 0.001 versus background. 
cell populations that were coll ected at the interphase between 1.07/ 
1.08 g/ml and 1.08/1.085 g/ml (Fig SA). It was noted that 17.4 ± 
1.9% of the cells belonged to the population with the lowest 
density, which was significantly resistant to stimulation with 
RANTES, IL-s, or GM-CSF, in comparison to the normodense cell 
populations (Fig sB). In contrast, there were no significant differ-
ences in the chemiluminescence response of the second hypodense 
cell population (21.3 ± 1.8% of the eosinophils), as compared with 
normodense eosinophils (Fig sB). 
Effect of RANTES on Intracellular and Extracellular Pro-
duction ofH20 2 Based on functiona l assay systems, a significant 
extracellular H 20 2 production was detected upon stimulation with 
RANTES (100 ng/ml), IL-s (102 U / ml), or GM-CSF (102 U/ml) 
(105 ± 29, 496 ± 116, 344 ± 55, and 13 ± 3 counts X 10- 3 for 
IL-s and GM-CSF induced a significant intracellular production of 
H 20 2 , no significant responses were detected in RANTES-stimu-
lated eosinophils (4.6 ± 0.9, 36.5 ± 9.1, 58.2 ± 19.8, and 3.3 ± 
0.3 integral intensity counts X 10- 3 for RANTES, IL-S, GM-CSF, 
and medium, respectively) . Both intracellular as well as extracellu-
lar production ofH20 2 were blocked completely in the presence of 
cytochalasin B (data not shown). Identical results were obtained 
when hydrogen peroxide production was visualized by an ultra-
structural technique. Upon stimulation with RANTES, the reac-
tion product was observed only on the outer surface of the plasma 
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Figure 3. Representative time course of the chemiluminescence response 
upon stimulation with recombinant human RANTES, IL-5, and GM-CSF 
in human eosinophils. MED, background, induced by addition of medium 
alone. Values represent the mean ± SD of six measurements on a single 
healthy nonatopic blood donor. Measurements were done using a Biolumat 
LB9S0SC. 
membrane (Fig 6A). Hydrogen peroxide production appeared to be 
RANTES, IL-5, GM-CSF, and medium, respectively). Whereas 
"focused" on distinct parts of the plasma membrane. In contrast, 
there were no signs of intracellular production of H 20 2 • Upon 
stimulation with IL-5 or GM-CSF, however, significant amounts of 
the reaction product were observed at the outer surface of the plasma 
membrane, mainly between adjacent cells, and particularly at the 
end of the pseudopodia, but also at the luminal part of the small 
intracytoplasmic vacuoles (Fig 6B,C). Extracellular as well as intra-
cellular production ofROS was completely inhibited by cytochala-
sin B (data not shown). 
Effect ofRANTES on the Release ofEep and EPO In con-
trast to its effect on eosinophil oxidative metabolism, no significant 
exocytosis of EPO and ECP (Fig 7) in the supernatant could be 
detected even at highest concentrations ofRANTES. Similar results 
were obtained for MIP-1a, IL-5, or GM-CSF (data not shown). 
Significant release of both proteins was observed only upon stimu-
lation with C5a in presence of cytochalasin B. Increase of the incu-
bation time from 60 to 120 min did not induce any significant 
change in the results (Fig 7). 
DISCUSSION 
In addition to its chemotactic activity, RANTES was shown to be a 
potent activator of the oxidative burst in eosinophils in this study. 
Production of reactive oxygen species associated with the release of 
toxic granule proteins determines the tissue-destructive power of 
eosinophils [1]. Eosinophil peroxidase, as a constituent of eosinophil 
granules, catalyzes the oxidation of various targets by hydrogen 
peroxide in the presence of halide, particularly bromide [351. Acti-
vation of this system results not only in the generation of halogen at-
ing oxidants, but also in the production of additional powerful 
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Figure 4. Effect of pertussis toxin and staurosporine on the chemilumines-
cence response of human eosinophils induced by recombinant human 
RANTES, IL-5, and GM-CSF. A) Effect of pertussis toxin on RANTES-
induced CL response. Eosinophils were incubated for 90 min at 37'C in the 
presence or absence of pertussis toxin, washed, resuspended in test buffer, 
and stimulated with RANTES (100 ng/ml), IL-5 (10 V/ml), and GM-CSF 
(10 U IrnI) for 60 min at 37'C or remained unstimulated. Percent inhibition 
was calculated after subtraction of the background activity observed in unsti-
mulated cells. The results represent the mean ± SEM of tluee experiments 
on three healthy nonatopic blood donors. B) Dose-related inhibition of CL 
response induced by IL-5 (10 V/ml), GM-CSF (10 V/mI), orPMA (10 ngl 
ml). C) Effect of staurosporine. Eosinophils were preincubated with stauro-
sporine for 2 min at 37 ' C before addition of RANTES (190 ng/ml), IL-S 
(102 U/rnI), GM-CSF (102 U/ml), or medium (MED). Chemilumines-
cence response was measured for 60 min at 37'C. Results represent the 
mean ± SEM of four experiments on four healthy nonatopic blood donors. 
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Figure 5. Effect ofRANTES, IL-S, and GM-CSF on the oxidative burst of 
hypodense and n~rmodense eos~nophil. populations. Followin~ ccntrifuga-
tion of highly punned eosmophlls on dlscontmous Percoll density gradlcnts 
twO hypodense and two normodensc eosinophil populations were collected. 
A) Distribution of cosinophils on the gradicnt indicatcd as percent of total 
number; B) The different eosinophil populations were stimulated with 
RANTES (100 ng/ml), IL-S (102 V/ml), and GM-CSF (102 V/ml), orme-
dium as a control (MED), and the chemiluminescencc response was mea-
sured for 60 min at 37°C. Results represent the mean ± SEM of nve experi-
ments on nve healthy nonatopic blood donors. 
oxygen radicals, such as singlet oxygen [36] . Release of these toxic 
agents by eosinophils during aller:gic in~ammation [2-~] is now 
considered to be a major pathogel1lc step 111 the pathophYSIOlogy of 
atopic dise~ses. " . 
Lucigen111-dependent CL represents a highly sensItive measure 
for the production ofROS, pa~ticularly for the release of superox!de 
anion, because ~ 70% of the Signal could be blocked by superoxlde 
dismutase [19] . Therefore, this technique was used to investigate 
the effect of RANTES on human eosinophils. Based on this assay 
system, maximal responses induced by RANTES were only 30% of 
optimal effects induced by IL-S or GM-CSF. Significant CL re-
sponses were only seen in a very small dose range, from 10 to 
100 ng/ml. However, there may be remarkable differences be-
tween natural and recombinant human chemokines, proabaly due to 
variations in the tertiary structure of the proteins (J. Schroder, per-
sonal communication). 
When other members of the chemokine family were tested, only 
MIP-1a, which was recently shown to be an activator ofbasophils 
and mast cells [37], induced a small but statistically significant CL 
response in eosinophils. This is in contrast to a previous report [12] 
showing the MIP-1a induced a chemotactic response in eosinophils 
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FiJ?lUe 6. Vltr~structural detection ofH20 2 production by human eosino-
phlls by recombmant human RANTES, IL-S and GM-CSF. A) Eosinophils 
of a h~althy nonatopic blood donor stimulated with RANTES (100 ng/ml), 
30. mm .at 37 ° C, ultrastructural detection of hydrogen peroxide; B) eosino-
phlls stimulated with IL-S (102 V/ ml), 30 min at 37"C, ultrastructural 
detectIOn of hydrogen peroxide; C) eosinophils stimulated with GM-CSF 
p02 V Iml], 30 min at 37"C, ultrastructural detection of hydrogen perox-
Ide. Arrows, production of hydrogen peroxidc is visualizcd by the detection 
of the electron-dense precipitate of Ce(OHhOOH (for details see Materials 
arId Methods) . Thc experiment is representative for nve essentially identical 
experiments on healthy nonatopic blood-donors. 
but no production of hydrogen peroxide in a luminol-dependent 
CL system. This may be explained by the lack of sensitiviry of that 
method as compared to the highly sensitive photon-imaging system 
used in our study [21] . Nevertheless, MIP-l,B, which is more ho-
mologous to MIP-1a than is MIP-la to RANTES [10], did not 
influence eosinophil chemotaxis [12] and the release of ROS. The 
discrepancy between homology and biologic activity of these re-
lated molecules is further supported by their capability to attract 
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Figure 7. Retease of EPO and ECP by eosinophils of healthy 110natopic 
blood-donors upon stimulation with RANTES, MCP-1, and C5a. Eosino-
phils were stimulated with recombinant human RANTES (100 ng/ml) and 
MCP-1 (100 ng/ml) in the presence or absence of cytochalasin B (5Ilg/ml) 
for 60 or 120 min at 37'C. Recombinant human C5a (10-7 M) was used as a 
positive control. EPO activity was measured in supernatants using a highly 
sensitive enhanced luminescence assay. ECP concentration was determined 
by means of a double-antibody radioimmunoassay. MED, spontaneous re-
lease after addition of medium. Values represent the mean ± SEM of tripli-
cate experiments on four to five healthy nonatopic blood donors .••• p s 
0.001 versus MED. 
different lymphocyte populations [38,39]. In addition, MCP-1, an 
additional member .of the C-C ~ranch represe.nting a potent direct 
activator of basophil degranulation [40,41], did not show any sig-
nificant effect on eosinophil chemotaxis [42] and respiratory burst. 
These differences may be partially explained by the observation that 
MIP-1a, MIP-1P, and MCP-1, and RANTES bind to a common 
receptor but with varying affinities [43]. The RANTES/MIP-la 
receptor was recently shown to belong to the G-protein-coupled 
receptor superfamily [44]. Our data clearly establish a role for per-
tussis toxin-sensitive G; proteins in the activation of the respiratory 
burst in eosinophils upon stimulation with RANTES, as well as 
with IL-5 or GM-CSF. Moreover, because staurosporine, an effec-
tive inhibitor of phospholipid/Ca++-dependent proteinkinase C 
(PKC) [31,32], and wortmannin, an inhibitor of a pathway leading 
to the activation of phospholipase D that is independent from Ca++ 
influx or PKC activation [33,34], completely abrogated the produc-
tion of reactive oxygen species induced by all stimuli tested, signal 
transduction may involve both a PKC-dependent and -independent 
step. 
Like IL-S, RANTES was proven to be an eosinophil-selective 
stimulus of eosinophil oxidative metabolism whereas GM-CSF is 
able to activate both eosinophils and PMNs [9,26]. Eosinophil CL 
responses upon stimulation with RANTES were comparable to the 
effect of classical eosinophil chemotaxins, such as C5a or PAF [45], 
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starting immediately after addition of the stimulus, whereas IL-S-
or GM-CSF - induced effects were preceded by a short lag phase. 
These differences may be due to distinct changes of the cytoskele-
ton, which will be discussed below. Upon stimulation with 
RANTES only a part of the eosinophils showed signs of activation. 
This may partially be explained by our finding that a part of the 
"hypodense" eosinophils [18], which were detected even in normal 
nonatopic blood donors, showed significantly reduced CL responses 
following stimulation with IL-5, GM-CSF, and, particularly, with 
RANTES. At present, it can only be speculated whether these cells 
are "deactivated" to specific stimulation as a result of preactivation 
with RANTES in vivo or during isolation by RANTES derived from 
platelets [11]. Because another part of the hypodense cells showed 
responses that were not different from normodense cells, changes 
in susceptibility are possibly due to different expression of the 
RANTES/MIP-1a receptor. However, the latter hypothesis could 
also explain interindividual differences of susceptibility to 
RANTES (data not shown). 
In contrast to RANTES, the three-dimensional appearance of 
eosinophils upon stimulation with IL-S or GM-CSF was different . 
Polarization, particularly induced by IL-S [46], usually represents a 
characteristic feature of inflammatory cells responding to chemo-
tactic factors [47]. Because all cytokines tested are chemotactic for 
eosinophils [48], the different cell shape of RANTES-stimulated 
eosinophils cannot be explained simply by different functional ac-
tivities. All morJ'hologic changes, however, could be blocked by 
cytochalasin B [28], supporting the concept of stimulus-specific 
alterations of the cytoskeleton, which may be restricted to receptor-
specific transductional events. 
Based on TEM, morphologic changes, which resembled those of 
activated tissue eosinophils, were noted upon stimulation with 
RANTES, GM-CSF, or IL-5. These included decreased numbers of 
specific granules, increased numbers of small dense granules [49], 
and increased numbers of membrane-bound large lipid bodies [50]. 
Furthermore, large amounts of elongated smooth tubules were ob-
served in the cytoplasma of these eosinophils. Moreover, increased 
numbers of so-called microgranules, as a part of the intracytoplas-
mic tubulo-vesicular structure representing a unique finding for 
eosinophils [51]. were found regularly upon stimulation with 
RANTES. Ultrastructural alterations of secondary granules, partic-
ularly the loss of matrix and the appearance of light vesicles, were 
pronounced in RANTES-stimulated eosinophils, but could also be 
seen with IL-S and GM-CSF. 
IL-5 and, to a lesser degree, GM-CSF, regularly induced the 
formation of tubulo-vesicular structures in the matrix of specific 
granules. These structures are thought to represent integral compo-
nents of a specific granule matrix that a.re masked by the racked 
enzymic contents and only disclosed during granule lysis [52 . Most 
of these characteristic findings have been noted previously in nor-
mal human eosinophils undergoing "exocytosis" [53,54]. Based on 
functional and immunologic assay systems, however, no significant 
release of EPO and ECP could be detected upon stimulation with 
RANTES, IL-5, or GM-CSF. Comparable results have been pub-
lished recently for IL-5 and GM-CSF [55]. In contrast, there are two 
reports describing a RANTES-induced release of ECP [12,13]. In 
the first paper, the amount of ECP released in the absence of cyto-
chalasin B was comparable to stimulation with PAF (10-7 M). In 
the second report, RANTES stimulated the release of ECP only in 
the presence of cytochalasin B, with optimal effects corresponding 
to 25% of C5a (10-7 M) . In contrast to a significant release of both 
ECP and EPO with CSa in the presence of cytochalasin B [31], we 
were unable to reproduce these findings with RANTES. In our 
experiments, however, eosinophils were tested at a lower cell den-
sity (104 cells/well) to avoid contact activation, because activated 
cells may also disrupt during centrifugation. 
Based on ultrastructural findings, human eosinophils have rarely 
been shown to extrude recognizable specific granules to the cells' 
exterior upon cytokine stimulation. However, eosinophils cultured 
in the presence of IL-5 were found to lose all secondary granules 
[56] . It is possible that the transport of granule contents by loaded 
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vesicles, probably identical with the so-called small dense granules, 
represents a mechanism of emptying secondary granules in the ab-
sence of classical granule exocytosis. Therefore, the term "piece-
meal degranulation" was coined to describe that type of release 
reaction. RANTES, particularly, stimulated the formation of small-
sized dense granules that were originally thought to reflect the 
synthesis of immature new granules as a consequence of initiation of 
the secretory process [53]. However, at present only mast cells were 
shown to "regranulate" following degranulation, as shown by their 
synthesis of new secretory material and the function of mature 
cytoplasmic granules [57]. Ultrastructural findings obtained with 
IL-5, GM-CSF, and, particularly, with RANTES, therefore, 
strongly suggest intracellular mobilization or translocation of toxic 
granule proteins. Therefore, a localized "piecemeal degranulation" 
may contribute to the changes of eosinophil density observed upon 
stimulation with RANTES [13] and IL-5 [58). This hypothesis was 
supported further by the demonstration of a localized production of 
hydrogen peroxide by cytokine-stimulated eosinophils, which was 
completely blocked in the presence of cytochalasin B. These data 
strongly support the concept that the production ofROS induced by 
these cytokines is dependent on the adherence of the cells to an 
appropriate surface [59]. 
Based on these findings it is evident that RANTES represents a 
potent eosinophil -specific activator of the oxidative metabolism in 
these proinflammatory effector cells. In addition to its chemotactic 
activity on T cells and eosinophils, therefore, RANTES may be an 
attractive candidate responsible for the selective activation of eosin-
ophils in the skin of patients with atopic dermatitis, triggering their 
toxic capacities. 
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ANNOUNCEMENT 
The Second Annual International Summit on "Cutaneous Antifungal Therapy: Update on 
Management and New Therapy for the Clinician" will be held November 10-13,1994 at The 
Four Seasons Hotel, Boston, Massachusetts. The Co-sponsors and Scientific Program Commit-
tee are Boni E. Elewski, M.D., Case Western Reserve University and University Hospitals of 
Cleveland; Richard B. Odom, M.D., University of California, San Francisco; R.J. Hay, D.M., 
F.R.C.P., M.R.C.Path., St. John'S Institute of Dermatology, London; Hideoki Ogawa, M.D., 
Ph.D., Juntendo University, Tokyo. 
Accreditation: The American Academy of Dermatology has certified that this educational 
activity has been recognized for 24 hours of AAD Physician's Category I credit. The Interna-
tional Summit has been certified for 18.25 hours and the Mycology Workshop has been 
recognized for 5.5 hours. 
BriifProgram Description: Speakers from Europe, North American, South America, and Asia 
will convene to present state-of-the-art lectures on the latest scientific and clinical advances in 
the field of cutaneous antifungal therapy. In addition, there will be a mycology workshop, 
stimulating panel discussions, scientific poster and oral presentations, and scheduled social 
events. Major topics include tinea capitis, yeast infections, fungal foot infections, onychomyco-
sis, and systemic infections. 
For more information call Educational Meeting Management, Inc., 23550 Commerce Park 
Road, Suite 2 Beachwood, OH 44122. Phone (216) 831-6080; FAX (216) 831-0032. 
